tirzepatide and chronic kidney disease Renal effects of GLP-1 receptor agonists in individuals with type 2 diabetes: seeds of a promising future | Endocrine Tirzepatide confers renal protection in

The most common modifiable risk factors for metabolic syndrome include: Excess weight, especially in the abdomen or belly A diet high in ultra-processed foods Lack of exercise, or sedentary lifestyle Tobacco and alcohol use Sleep apnea and impaired sleep Other metabolic syndrome risk factors are out of our control and cant be changed: Family history of type 2 diabetes or metabolic syndrome Advanced age Presence of polycystic ovarian syndrome (PCOS) in women How Is Metabolic Syndrome Diagnosed

Keep supplemental magnesium at or under the 350 mg/day upper limit (NIH Office of Dietary Supplements) and vitamin D at or under 4,000 IU/day (NIH Office of Dietary Supplements) unless a prescriber directs otherwise

Preclinical studies have not reported significant adverse effects

Your PlexusDx clinical team will recommend a starting pace based on your medical history, concurrent medications, and treatment goals

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat

10.1016/j.jep.2022.115382 91 LiuY.TanY.HuangJ.WuC.FanX.StalinA.et al (2022)